Top Australian shares to buy right now with $2,500

A woman wearing dark clothing and sporting a few tattoos and piercings holds a phone and a takeaway coffee cup as she strolls under the Sydney Harbour Bridge which looms in the background.

With the market experiencing heightened volatility in 2026, a number of high-quality names are trading below their recent highs.

While disappointing for existing shareholders, this weakness could give the rest of us a chance to build positions in companies with strong long-term potential.

Here are three Australian share ideas that could be worth considering with a $2,500 investment right now.

Pro Medicus Ltd (ASX: PME)

The first Australian share that continues to stand out is Pro Medicus.

Rather than competing across the entire healthcare software landscape, the company has focused on doing one thing exceptionally well. Its imaging platform is designed for speed and efficiency, which has helped it win contracts with some of the world’s largest healthcare providers.

This focus has allowed it to build a premium product that commands strong margins and long-term contracts. Once embedded, its software becomes difficult to replace, giving the business a durable revenue base.

With healthcare systems increasingly prioritising productivity and workflow improvements, Pro Medicus appears well placed to continue expanding its footprint.

REA Group Ltd (ASX: REA)

Another Australian share that could be a smart pick is REA Group.

It has built a dominant position in online property listings, but what makes it particularly interesting is how it continues to deepen its role in the property ecosystem.

Beyond listings, REA is increasingly monetising its audience through data-driven products, advertising solutions, and financial services. This allows it to extract more value from each property transaction without needing a large increase in listings volumes.

Even in softer property markets, this model can support growth by lifting yields per listing and expanding into adjacent services.

With strong brand recognition and a highly engaged user base, REA remains a powerful platform business.

TechnologyOne Ltd (ASX: TNE)

A final Australian share to consider is TechnologyOne.

The enterprise software provider has been quietly building momentum through its transition to a cloud-based model. This shift is changing the shape of its revenue, making it recurring and predictable over time.

Rather than chasing rapid expansion, TechnologyOne has focused on steadily increasing its customer base across government, education, and corporate sectors.

This disciplined approach has supported consistent growth while maintaining profitability, which is relatively rare among software companies.

As more organisations move their operations to the cloud, TechnologyOne’s long-standing relationships and industry-specific solutions could continue to drive adoption.

The post Top Australian shares to buy right now with $2,500 appeared first on The Motley Fool Australia.

Should you invest $1,000 in Pro Medicus right now?

Before you buy Pro Medicus shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Pro Medicus wasn’t one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys…

* Returns as of 20 Feb 2026

.custom-cta-button p {
margin-bottom: 0 !important;
}

More reading

Motley Fool contributor James Mickleboro has positions in Pro Medicus, REA Group, and Technology One. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Technology One. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus and Technology One. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.